The current literature has rigorously established how adaptive immunity associated with A2AR promotes head and neck cancer.26–28 However, it has been neglected that a high amount of adenosine can also trigger neuronal A2AR,6,29 a potential contributor to OSCC progression. Here, ADORA2A is linked to head and neck cancer.